Naproxcinod regulatory update

FDA will hold a joint panel meeting on May 12 to discuss an NDA from NicOx for naproxcinod to treat the signs and symptoms of osteoarthritis. The Arthritis Drugs and the Drug Safety and Risk Managemen...